You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-Hodgkin lymphoma,

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
    • (no location specified)
    Sep 19, 2023

    Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Trial in Beijing (JS203 for Injection)

    Not yet recruiting
    • Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
    • JS203 for Injection
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Nov 11, 2022

    NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

    Recruiting
    • NHL
    • NHL, Relapsed, Adult
    • Birmingham, Alabama
    • +4 more
    May 31, 2023

    Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Hodgkin Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Jan 25, 2023

    Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in Changsha, Suzhou (U16)

    Recruiting
    • Relapsed or Refractory Non-Hodgkin's Lymphoma
    • Changsha, Hunan, China
    • +1 more
    Mar 13, 2023

    Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

    Active, not recruiting
    • Aggressive Non-Hodgkin Lymphoma
    • +9 more
    • Cryosurgery
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 9, 2022

    Non-hodgkin's Lymphoma Trial in Beijing (GNC-038)

    Recruiting
    • Non-hodgkin's Lymphoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Jan 12, 2023

    Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +6 more
    • CB-010
    • +2 more
    • Scottsdale, Arizona
    • +7 more
    Aug 19, 2022

    Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Jinan (CAR-T cells)

    Recruiting
    • Relapsed Non-Hodgkin Lymphoma
    • +2 more
    • CAR-T cells
    • Jinan, Shandong, China
      The Second People's Hospital of Shandong Province
    Jun 14, 2022

    Non-Hodgkin Lymphoma, Multiple Myeloma Trial in China (Maplirpacept)

    Not yet recruiting
    • Non-Hodgkin Lymphoma
    • Multiple Myeloma
    • Beijing, Beijing, China
    • +3 more
    May 31, 2023

    Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin Trial in Ribeirao Preto (CART-19)

    Not yet recruiting
    • Leukemia, Acute Lymphoblastic
    • Lymphoma, Non-Hodgkin
    • CART-19
    • Ribeirao Preto, Sao Paulo, Brazil
      Ribeirao Preto School of Medicine, University of Sao Paulo
    Oct 23, 2023

    Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

    Active, not recruiting
    • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
    • +22 more
    • External Beam Radiation Therapy
    • Orbital Radiation
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 9, 2022

    Advanced Solid Tumors, Relapsed Or Refractory Non-Hodgkin Lymphoma Trial in Zhengzhou, Hangzhou (YH004)

    Not yet recruiting
    • Advanced Solid Tumors
    • Relapsed Or Refractory Non-Hodgkin Lymphoma
    • Zhengzhou, Henan, China
    • +1 more
    Oct 20, 2022

    CB-Long-Term Safety Study (CB-LTSS)

    Enrolling by invitation
    • Lymphoma, Non-Hodgkin
    • +7 more
    • Allogeneic CAR-T therapy
    • Irvine, California
    • +3 more
    Nov 18, 2022

    Non-Hodgkin's Lymphoma and Hodgkin's Disease

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Hodgkin's Disease
      • Stanford, California
        Stanford University School of Medicine
      Sep 9, 2022

      Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

      Not yet recruiting
      • Mature B-Cell Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 6, 2022

      Non-Hodgkin's Lymphoma Trial (MBS303)

      Not yet recruiting
      • Non-Hodgkin's Lymphoma
      • (no location specified)
      Apr 6, 2023

      Non-Hodgkin Lymphoma Trial in Milano (Romiplostim)

      Completed
      • Non-Hodgkin Lymphoma
      • Milano, Italy
        Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
      Aug 10, 2022

      Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in China (AXT-1003)

      Not yet recruiting
      • Relapsed or Refractory Non-Hodgkin's Lymphoma
      • Beijing, China
      • +3 more
      Jul 20, 2023

      NonHodgkin's Lymphoma Refractory Trial in El Segundo (N803, CD19t-haNK suspension, Cyclophosphamide)

      Not yet recruiting
      • NonHodgkin's Lymphoma Refractory
      • El Segundo, California
        CSSIFM
      Nov 9, 2022

      Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive

      Active, not recruiting
      • Aggressive B-Cell Non-Hodgkin Lymphoma
      • fractionated first dose rituximab
      • Geneva, Switzerland
        University Hospital Geneva
      Apr 21, 2023

      Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas Trial in Boston (Imprime PGG, Rituximab)

      Completed
      Has Results
      • Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Sep 20, 2022

      Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

      Active, not recruiting
      • Non Hodgkin Lymphoma
      • UCD19 CAR T Cells
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 1, 2022

      High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

      Not yet recruiting
      • High Grade B-Cell Non-Hodgkin's Lymphoma
      • +3 more
      • Anti-CD19-CAR CMV-specific T-lymphocytes
      • +9 more
      • Duarte, California
        City of Hope Medical Center
      Apr 5, 2023